glp 1 agonist pregnancy From JAMA: #GLP-1 receptor exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja Is it unsafe to use

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

This guide examines peer-reviewed research on EVOO and GLP-1 secretion, hydroxytyrosol and insulin sensitivity, oleocanthal and inflammation, and why these olive-specific compounds are distinct from other dietary polyphenols

Some studies report solid food remnants in the stomach even after prolonged fasting

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation

This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS